Treatment specific utility-weightings are needed for cost-utility analysis in metastatic melanoma: reply from the authors.

Saved in:
Bibliographic Details
Title: Treatment specific utility-weightings are needed for cost-utility analysis in metastatic melanoma: reply from the authors.
Authors: Matter-Walstra K; Institute of Pharmaceutical Medicine/ECPM, University Basel, Basel, Switzerland. klazien.matter@unibas.ch.; SAKK Coordinating Centre, Bern, Switzerland. klazien.matter@unibas.ch., Braun R; Department Dermatology, University Hospital Zürich, Zürich, Switzerland., Kolb C; SAKK Coordinating Centre, Bern, Switzerland., Ademi Z; Institute of Pharmaceutical Medicine/ECPM, University Basel, Basel, Switzerland., Dummer R; Department Dermatology, University Hospital Zürich, Zürich, Switzerland., Pestalozzi BC; SAKK Coordinating Centre, Bern, Switzerland.; Department Oncology, University Hospital Zürich, Zürich, Switzerland., Schwenkglenks M; Institute of Pharmaceutical Medicine/ECPM, University Basel, Basel, Switzerland.
Source: The British journal of dermatology [Br J Dermatol] 2016 Feb; Vol. 174 (2), pp. 463. Date of Electronic Publication: 2016 Jan 20.
Publication Type: Letter; Comment
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26787297
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Treatment specific utility-weightings are needed for cost-utility analysis in metastatic melanoma: reply from the authors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Matter-Walstra+K%22">Matter-Walstra K</searchLink>; Institute of Pharmaceutical Medicine/ECPM, University Basel, Basel, Switzerland. klazien.matter@unibas.ch.; SAKK Coordinating Centre, Bern, Switzerland. klazien.matter@unibas.ch.<br /><searchLink fieldCode="AU" term="%22Braun+R%22">Braun R</searchLink>; Department Dermatology, University Hospital Zürich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kolb+C%22">Kolb C</searchLink>; SAKK Coordinating Centre, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ademi+Z%22">Ademi Z</searchLink>; Institute of Pharmaceutical Medicine/ECPM, University Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dummer+R%22">Dummer R</searchLink>; Department Dermatology, University Hospital Zürich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pestalozzi+BC%22">Pestalozzi BC</searchLink>; SAKK Coordinating Centre, Bern, Switzerland.; Department Oncology, University Hospital Zürich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schwenkglenks+M%22">Schwenkglenks M</searchLink>; Institute of Pharmaceutical Medicine/ECPM, University Basel, Basel, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220004041%22">The British journal of dermatology</searchLink> [Br J Dermatol] 2016 Feb; Vol. 174 (2), pp. 463. <i>Date of Electronic Publication: </i>2016 Jan 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0004041 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2133 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070963%22">00070963 </searchLink><i>NLM ISO Abbreviation: </i>Br J Dermatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26787297
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/bjd.14279
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 463
    Titles:
      – TitleFull: Treatment specific utility-weightings are needed for cost-utility analysis in metastatic melanoma: reply from the authors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Matter-Walstra K
      – PersonEntity:
          Name:
            NameFull: Braun R
      – PersonEntity:
          Name:
            NameFull: Kolb C
      – PersonEntity:
          Name:
            NameFull: Ademi Z
      – PersonEntity:
          Name:
            NameFull: Dummer R
      – PersonEntity:
          Name:
            NameFull: Pestalozzi BC
      – PersonEntity:
          Name:
            NameFull: Schwenkglenks M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2016 Feb
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2133
          Numbering:
            – Type: volume
              Value: 174
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: The British journal of dermatology
              Type: main
ResultId 1